We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Glucose Monitoring System Designed for Accuracy

By LabMedica International staff writers
Posted on 29 Jul 2013
Recently more attention has been drawn to the accuracy requirements for blood glucose monitoring systems (BGMS) for home use as well as those for hospital use.

Tighter accuracy criteria are being introduced internationally for BGMS and therefore newer systems need to be evaluated for point-of-care testing (POCT) of blood glucose, a valuable biomarker for the management of patients with diabetes and other conditions. More...


Collaborating scientists from three different institutions and the commercial manufacturer evaluated a BGMS in a multicenter study for precision, interference, and system accuracy using 503 blood samples from capillary, venous, and arterial sources. Included in the study was interference testing, both hematocrit and other substances, and accuracy evaluations. The institutes were the Rainier Clinical Research Center (Renton, WA, USA), the Duke University Medical Center (Durham, NC, USA), and MassResearch LLC (Waltham, MA, USA).

The FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System (Abbott Diabetes Care; Alameda, CA, USA) is designed to simplify POCT for healthcare professionals, providing features that enhance the reliability of the testing process and support compliance with POCT policies. The FreeStyle Precision Pro blood glucose-test strip is individually sealed, and each test strip contains three electrodes, working, reference, and fill trigger. The circuit between the fill trigger and the reference electrodes must be detected by the meter before the test will start. The minimum sample volume required is 0.6 μL and the test time is five seconds.

The FreeStyle Precision Pro system demonstrated acceptable precision, no interference across a hematocrit range of 15% to 65%, and, except for xylose, no interference from 24 of 25 potentially interfering substances. From the individual results of various blood sample types, 97.3% to 98.9% agreed within ±12 mg/dL of the laboratory analyzer values at glucose concentrations less than 100 mg/dL and within ±12.5% of the laboratory analyzer values at glucose concentrations equal to or greater than 100 mg/dL.

The authors concluded that the FreeStyle Precision Pro system makes more measurements and uses more signals from the glucose electrochemical reaction to increase accuracy; it also performs more integrity checks to detect potential errors during each glucose test. The study was published on June 5, 2013, in the journal Clinica Chimica Acta.

Related Links:

Rainier Clinical Research Center
Duke University Medical Center
Abbott Diabetes Care



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.